Petco Health Wellness Company Inc
For the period ended May 3, 2025. Filed Jun 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
May 3, 2025 · Filed Jun 6, 2025
WOOF$2.93-5.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
| Thirteen weeks ended | ||
|---|---|---|
| May 3,2025 | May 4,2024 | |
| Cash flows from operating activities: | ||
| Net loss | $(11,661) | $(46,483) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 49,365 | 49,587 |
| Amortization of debt discounts and issuance costs | 1,246 | 1,218 |
| Provision for deferred taxes | (9,218) | (13,365) |
| Equity-based compensation | 9,420 | 17,434 |
| Impairments, write-offs and losses on sale of fixed and other assets | 446 | 3,508 |
| Income from equity method investees | (4,610) | (4,886) |
| Amounts reclassified out of accumulated other comprehensive loss | (212) | (1,129) |
| Non-cash operating lease costs | 102,132 | 103,637 |
| Other non-operating loss | — | 2,665 |
| Changes in assets and liabilities: | ||
| Receivables | 4,229 | 2,987 |
| Merchandise inventories | 7,857 | 3,076 |
| Prepaid expenses and other assets | (1,673) | (4,511) |
| Accounts payable and book overdrafts | (19,028) | (19,538) |
| Accrued salaries and employee benefits | (51,130) | (5,474) |
| Accrued expenses and other liabilities | 12,426 | 5,902 |
| Operating lease liabilities | (103,780) | (104,181) |
| Other long-term liabilities | (1,263) | 1,139 |
| Net cash used in operating activities | (15,454) | (8,414) |
| Cash flows from investing activities: | ||
| Cash paid for fixed assets | (28,412) | (32,641) |
| Cash paid for acquisitions, net of cash acquired | — | (100) |
| Proceeds from investments | — | 998 |
| Proceeds from sale of assets | 1,279 | — |
| Net cash used in investing activities | (27,133) | (31,743) |
| Cash flows from financing activities: | ||
| Borrowings under long-term debt agreements | — | 173,000 |
| Repayments of long-term debt | — | (173,000) |
| Debt refinancing costs | — | (2,955) |
| Payments for finance lease liabilities | (1,143) | (1,444) |
| Proceeds from employee stock purchase plan and stock option exercises | 967 | 830 |
| Tax withholdings on stock-based awards | (158) | (2,059) |
| Net cash used in financing activities | (334) | (5,628) |
| Net decrease in cash, cash equivalents and restricted cash | (42,921) | (45,785) |
| Cash, cash equivalents and restricted cash at beginning of period | 181,665 | 136,649 |
| Cash, cash equivalents and restricted cash at end of period | $138,744 | $90,864 |
| Supplemental cash flow disclosures: | ||
| Interest paid, net | $31,112 | $34,357 |
| Income taxes paid | $630 | $1,282 |
| Supplemental non-cash investing and financing activities disclosure: | ||
| Accounts payable and accrued expenses for capital expenditures | $13,010 | $14,541 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.